Notice of Meeting, 27517-27518 [2017-12435]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 114 / Thursday, June 15, 2017 / Notices
pmangrum on DSK3GDR082PROD with NOTICES
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Academic
Research Enhancement Award.
Date: July 6, 2017.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Juraj Bies, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Dr., Rm. 4158, MSC 7806, Bethesda, MD
20892, 301–435–1256, biesj@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–15–
315 Counter Act Exploratory Grants.
Date: July 7, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Monaco, 2 North Charles
Street, Baltimore, MD 21201.
Contact Person: Geoffrey G Schofield,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040–A,
MSC 7850, Bethesda, MD 20892, 301–435–
1235, geoffreys@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR16–027:
Commercialization Readiness Pilot.
Date: July 7, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz Carlton Hotel, 1150 22nd Street
NW., Washington, DC 20037.
Contact Person: Cristina Backman, Ph.D.,
Scientific Review Officer, ETTN IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5211,
MSC 7846, Bethesda, MD 20892, 301–480–
9069, cbackman@mail.nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group; AIDSassociated Opportunistic Infections and
Cancer Study Section.
Date: July 7, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Four Seasons Hotel, 1111 14th St.,
Denver, CO 80202.
Contact Person: Eduardo A. Montalvo,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108,
MSC 7852, Bethesda, MD 20892, (301) 435–
1168, montalve@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Emerging Technologies in
Neuroscience.
Date: July 7, 2017.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
VerDate Sep<11>2014
14:10 Jun 14, 2017
Jkt 241001
Contact Person: Sharon S. Low, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5104,
MSC 5104, Bethesda, MD 20892–5104, 301–
237–1487, lowss@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Clinical Neurological and
Neuropsychiatric Disorders and Aging.
Date: July 7, 2017.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Samuel C. Edwards, Ph.D.,
Chief, Brain Disorders and Clinical
Neuroscience, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5210, MSC 7846, Bethesda, MD
20892, (301) 435–1246, edwardss@
csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 9, 2017.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–12363 Filed 6–14–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Emerging
Technologies Review I.
Date: July 10–11, 2017.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Rockville, MD 20852.
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
27517
Contact Person: Shamala K. Srinivas,
Ph.D., Scientific Review Officer, Office of
Referral, Review, and Program Coordination,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W539, Bethesda, MD 20892–
9750, 240–276–6442, ss537t@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Emerging
Technologies Review II.
Date: July 10–11, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Rockville, MD 20852.
Contact Person: Caterina Bianco, MD,
Ph.D., Acting Chief, Scientific Review
Officer, Resources and Training Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W110, Bethesda, MD
20892–9750, 240–276–6459, biancoc@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Informatics
Tools for Cancer Surveillance.
Date: July 27, 2017.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
6W030, Bethesda, MD 20892–9750,
(Telephone Conference Call).
Contact Person: Nadeem Khan, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W260, Bethesda, MD 20892–
9750, 240–276–5856, nadeem.khan@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: June 9, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–12387 Filed 6–14–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Notice of Meeting
Pursuant to Public Law 92–463,
notice is hereby given that the
Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Center for Substance Abuse Prevention
E:\FR\FM\15JNN1.SGM
15JNN1
27518
Federal Register / Vol. 82, No. 114 / Thursday, June 15, 2017 / Notices
(CSAP) National Advisory Council will
meet on August 2, 2017, 3:30 p.m.–4:30
p.m., in Rockville, MD.
The meeting will include the review,
discussion, and evaluation of grant
applications reviewed by the Initial
Review Group, and involve an
examination of confidential financial
and business information as well as
personal information concerning the
applicants. Therefore, these meetings
will be closed to the public as
determined by the Acting Deputy
Assistant Secretary for Mental Health
and Substance Use, in accordance with
Title 5 U.S.C. 552b(c)(4) and (c)(6); and
5 U.S.C. App. 2, Section 10(d).
Committee Name: Substance Abuse
and Mental Health Services
Administration, Center for Substance
Abuse Prevention National Advisory
Council.
Date/Time/Type: August 2, 2017 3:30
p.m.–4:30 p.m. (CLOSED).
Place: SAMHSA Building, 5600
Fishers Lane, Rockville, MD 20857.
Contact: Matthew J. Aumen,
Designated Federal Officer, SAMHSA/
CSAP National Advisory Council, 5600
Fishers Lane, Rockville, MD 20857,
Email: Matthew.Aumen@
samhsa.hhs.gov.
DEPARTMENT OF THE INTERIOR
Carlos R. Castillo,
Committee Management Officer, SAMHSA.
Background
The Endangered Species Act of 1973,
as amended (ESA; 16 U.S.C. 1531 et
seq.), prohibits certain activities with
endangered and threatened species
unless the activities are specifically
authorized by a Federal permit. The
ESA and our implementing regulations
[FR Doc. 2017–12435 Filed 6–14–17; 8:45 am]
BILLING CODE 4162–20–P
Fish and Wildlife Service
[FWS–R3–ES–2017–N054;
FXES11130300000–178–FF03E00000]
Endangered and Threatened Wildlife
and Plants; Permit Applications
Fish and Wildlife Service,
Interior.
ACTION: Notice of availability; request
for comments.
AGENCY:
We, the U.S. Fish and
Wildlife Service, invite the public to
comment on the following applications
for a permit to conduct activities
intended to enhance the survival of
endangered or threatened species.
Federal law prohibits certain activities
with endangered species unless a permit
is obtained.
DATES: We must receive any written
comments on or before July 17, 2017.
ADDRESSES: Send written comments by
U.S. mail to the Regional Director, Attn:
Carlita Payne, U.S. Fish and Wildlife
Service, Ecological Services, 5600
American Blvd. West, Suite 990,
Bloomington, MN 55437–1458; or by
electronic mail to permitsR3ES@fws.gov.
FOR FURTHER INFORMATION CONTACT:
Carlita Payne, (612) 713–5343.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Applications Available for Review and
Comment
We invite local, State, Tribal, and
Federal agencies and the public to
comment on the following applications.
Please refer to the permit number when
you submit comments. Documents and
other information the applicants have
submitted with the applications are
available for review, subject to the
requirements of the Privacy Act (5
U.S.C. 552a) and Freedom of
Information Act (5 U.S.C. 552).
Permit Applications
Proposed activities in the following
permit requests are for the recovery and
enhancement of survival of the species
in the wild.
Application No.
Applicant
Species
TE24914C ......
Northern Research
Station, U.S.
Forest Service,
Amherst, MA.
Melody MyersKinzie, Indianapolis, IN.
Rusty patched bumble bee (Bombus
affinis).
Michigan, Minnesota, Wisconsin.
Conduct presence/ Capture, handle,
absence surveys.
hold, release.
New.
Clubshell (Pleurobema clava), fanshell
(Cyprogenia stegaria), fat pocketbook (Potamilus capax), northern
riffleshell
(Epioblasma
torulosa
rangiana),
pink
mucket
(pearlymussel) (Lampsilis abrupta),
purple cat’s paw pearlymussel
(Epioblasma obliquata obliquata),
rabbitsfoot
(Quadrula
cylindrica
cylindrica), rayed bean (Villosa
fabalis), rough pigtoe (Pleurobema
plenum),
sheepnose
mussel
(Plethobasus cyphyus), snuffbox
mussel
(Epioblasma
triquetra),
spectaclecase
(mussel)
(Cumberlandia monodonta), white
catspaw (pearlymussel) (Epioblasma
obliquata
perobliqua),
winged
mapleleaf (Quadrula fragosa).
Illinois, Indiana,
Iowa, Michigan,
Ohio, Wisconsin.
Conduct presence/
ab-sence surveys.
Renew.
pmangrum on DSK3GDR082PROD with NOTICES
TE82665A ......
VerDate Sep<11>2014
14:10 Jun 14, 2017
Jkt 241001
PO 00000
Frm 00057
Location
in part 17 of title 50 of the Code of
Federal Regulations (CFR) provide for
the issuance of such permits and require
that we invite public comment before
issuing permits for activities involving
endangered species.
A permit granted by us under section
10(a)(1)(A) of the ESA authorizes the
permittee to conduct activities with U.S.
endangered or threatened species for
scientific purposes, enhancement of
propagation or survival, or interstate
commerce (the latter only in the event
that it facilitates scientific purposes or
enhancement of propagation or
survival). Our regulations implementing
section 10(a)(1)(A) of the ESA for these
permits are found at 50 CFR 17.22 for
endangered wildlife species, 50 CFR
17.32 for threatened wildlife species, 50
CFR 17.62 for endangered plant species,
and 50 CFR 17.72 for threatened plant
species.
Fmt 4703
Sfmt 4703
Activity
E:\FR\FM\15JNN1.SGM
Type of take
Capture, handle,
release.
15JNN1
Permit action
]]>Agencies
[Federal Register Volume 82, Number 114 (Thursday, June 15, 2017)]
[Notices]
[Pages 27517-27518]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-12435]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Notice of Meeting
Pursuant to Public Law 92-463, notice is hereby given that the
Substance Abuse and Mental Health Services Administration's (SAMHSA)
Center for Substance Abuse Prevention
[[Page 27518]]
(CSAP) National Advisory Council will meet on August 2, 2017, 3:30
p.m.-4:30 p.m., in Rockville, MD.
The meeting will include the review, discussion, and evaluation of
grant applications reviewed by the Initial Review Group, and involve an
examination of confidential financial and business information as well
as personal information concerning the applicants. Therefore, these
meetings will be closed to the public as determined by the Acting
Deputy Assistant Secretary for Mental Health and Substance Use, in
accordance with Title 5 U.S.C. 552b(c)(4) and (c)(6); and 5 U.S.C. App.
2, Section 10(d).
Committee Name: Substance Abuse and Mental Health Services
Administration, Center for Substance Abuse Prevention National Advisory
Council.
Date/Time/Type: August 2, 2017 3:30 p.m.-4:30 p.m. (CLOSED).
Place: SAMHSA Building, 5600 Fishers Lane, Rockville, MD 20857.
Contact: Matthew J. Aumen, Designated Federal Officer, SAMHSA/CSAP
National Advisory Council, 5600 Fishers Lane, Rockville, MD 20857,
Email: Matthew.Aumen@samhsa.hhs.gov.
Carlos R. Castillo,
Committee Management Officer, SAMHSA.
[FR Doc. 2017-12435 Filed 6-14-17; 8:45 am]
BILLING CODE 4162-20-P
